Irina Rozhkova

Statistics

Publications

Citations

450

H-Index

Active since

2022

Affiliations

Chelyabinsk Regional Clinical Oncology Center(Current)

Regeneron (United States)

Polish Mother’s Memorial Hospital Research Institute

Batumi State Maritime Academy

Institute for Social Security and Services for State Workers

Irina Rozhkova is an author at Chelyabinsk Regional Clinical Oncology Center specializing in lung cancer pharmacotherapy, oncology, and cancer pharmacology.

Publications per year

2022–2024

Publications

Cemiplimab plus chemotherapy versus chemotherapy alone in non-small cell lung cancer: a randomized, controlled, double-blind phase 3 trial

Miranda Gogishvili, Tamar Melkadze, Tamta Makharadze et al. · Nature Medicine · 2022 · 301 citations · Full text

Medicine, Oncology, Pharmacology +15

Cemiplimab Plus Chemotherapy Versus Chemotherapy Alone in Advanced NSCLC: 2-Year Follow-Up From the Phase 3 EMPOWER-Lung 3 Part 2 Trial

Tamta Makharadze, Miranda Gogishvili, Tamar Melkadze et al. · Journal of Thoracic Oncology · 2023 · 98 citations · Full text

Medicine, Oncology, Pharmacology +15

RESILIENT Part 2: A Randomized, Open-Label Phase III Study of Liposomal Irinotecan Versus Topotecan in Adults With Relapsed Small Cell Lung Cancer

David R. Spigel, Afshin Dowlati, Yuanbin Chen et al. · Journal of Clinical Oncology · 2024 · 35 citations · Full text

Medicine, Oncology, Pharmacology +15

Quality of life with cemiplimab plus chemotherapy for first‐line treatment of advanced non–small cell lung cancer: Patient‐reported outcomes from phase 3 EMPOWER‐Lung 3

Tamta Makharadze, Ruben G.W. Quek, Tamar Melkadze et al. · Cancer · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15

1–4 of 4